Fundz

Biomakers reported raising $2.4 Million in an initial SEC Form D filing, from an offering of $8 Million

PRIVATEFeb 12, 2024

Amount Raised

$2.4 Million

$2.4 Million sold, per SEC Form D (first sale Jan 26, 2024)

Round Type

Seed

San FranciscoBiotechnology

Who to call at Biomakers, and when

A new round usually means Biomakers is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Biomakers raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Biomakers, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Biomakers. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Biomakers

Location

One Post Office Square

San Francisco, California, United States

About

Biomakers is a precision medicine and oncology intelligence company transforming clinical and genomic information into actionable insights for therapeutic and diagnostic development. Headquartered in San Francisco, with clinical laboratories in Mexico, Brazil, and Argentina, Biomakers operates across Latin America and the United States, enabling global partners to access diverse, high-quality data and biospecimens at scale.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Biomakers raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Biomakers's next move

See what Strategic adds

Biomakers raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.